In an attempt to amend the personal care products regulation, on January 13, 2017, Pete Sessions (R-TX) reintroduced a bill that amends the Federal Food, Drug, and Cosmetic Act to set forth provisions governing the regulation of cosmetics by FDA. The bill, titled the "Cosmetic Modernization Amendments of 2017" (H.R. 575), was previously introduced in 2015 (H.R. 4075) with no success. The bill proposes to redefine the term "cosmetic" so that "An article ... that is intended only for topical external use to alter the appearance by temporarily affecting the structure or any function of the human skin, and that is not the subject of an approved new drug application under section 505, shall, for purposes of this Act, be treated only as a cosmetic and not a drug." The bill would require cosmetic manufacturer registration; submission of cosmetic and ingredient statements; reporting by cosmetic manufacturers, packers, and distributors of any serious and unexpected adverse events likely caused by a cosmetic; inclusion of contact information on cosmetic labels for serious adverse event reporting; codification of good manufacturing practice standards; creation of an FDA program to evaluate cosmetic and cosmetic ingredient safety; and establishment and maintenance of a National Cosmetic Regulatory Databank.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
